Market Overview

Shire Still Confident In Baxalta Transaction Despite Treasury Headwinds


Shares of Shire PLC (ADR) (NASDAQ: SHPG) were trading higher by nearly 6 percent late Wednesday afternoon as the company issued a public comment regarding its proposed acquisition of Baxalta Inc (NYSE: BXLT).

Ireland-based Shire said in a press release it still "anticipates" the proposed merger would receive the necessary regulatory approval and will proceed as planned.

"The combination of Shire and Baxalta is based on a strong strategic rationale to create the leading global biotechnology company focused on rare diseases," Shire said in its press release. "The company currently expects to complete its proposed combination by mid-2016 as previously announced."

The Financial Times noted Shire's acquisition of Baxalta would free up tax benefits of up to $260 million by 2020. However, the publication cited analysts at Credit Suisse who said that the tax benefits may be uncertain.

"With Shire being an Irish tax domiciled company we are not clear to what extent these rules may be important," the analysts told the Financial Times. "But we do not see the possible loss of this level of tax as likely to derail management's strong desire to complete the transaction."


Related Articles (SHPG + BXLT)

View Comments and Join the Discussion!

Posted-In: Baxalta Financial Times Shire Shire Baxalta MergerAnalyst Color M&A

Latest Ratings

QEPPiper SandlerDowngrades1.0
CALMStephens & Co.Reiterates55.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at